AdipoLABs Co., Ltd. and Red & Blue Co., Ltd. from Korea, together with their Malaysian subsidiary, AdipoLABs Healthcare (M) Sdn Bhd, officially opened a new regional office for Asia-Pacific in Petaling Jaya, Malaysia, on December 4, 2025. The expansion marks a strategic move to strengthen the company's leadership in non-invasive healthcare and build a MedTech ecosystem in Malaysia and across ASEAN.
To commemorate the milestone, the company signed two Memoranda of Understanding (MoUs) with the University of Cyberjaya (UoC). The partnerships aim to drive healthcare innovation, clinical research, and talent development. "By uniting our hyperthermia technology with local expertise and academic rigour, we'll expedite the adoption of advanced solutions and improve patient outcomes worldwide," said Mr. Han Sung-ho, CEO of AdipoLABs Co., Ltd.
The first MoU establishes a comprehensive internship programme with UoC's Physiotherapy programmes under the Faculty of Health, offering six-month placements and potential job opportunities. Students will gain hands-on expertise with AdipoLABs' Pain Bot device, enhancing their skills in pain detection and treatment. Students from the School of Biomedical Engineering will support technical operations, strengthening after-sales service and device maintenance. Interns may also be placed at client facilities to demonstrate device effectiveness and provide on-site support.
The collaboration extends to clinical research, where UoC professors and students will conduct studies on AdipoLABs medical devices, generating evidence-based insights for publication in reputable journals. "We're thrilled to collaborate with the University of Cyberjaya to cultivate local talent and drive Malaysian healthcare innovation," said Dr. Isaac R. Joseph, Director of AdipoLABs Healthcare (M) Sdn Bhd.
A second MoU focuses on knowledge transfer and medical device donation. AdipoLABs Malaysia will donate a Pain Bot unit to UoC, giving students access to cutting-edge pain detection and treatment technology. Professor Dr. Yoo Seung-mo from South Korea, inventor of the Pain Bot, will serve as an Adjunct Professor at UoC, providing on-site training and remote mentorship.
AdipoLABs, a Ministry of Health-registered medical-device establishment under the Medical Device Authority, anchors this collaboration with regulatory credibility. "AdipoLABs' partnership with the University of Cyberjaya is a direct investment in the next generation of healthcare professionals," said Professor Dr. David Whitford, Vice-Chancellor of UoC.
For more information, visit University of Cyberjaya or AdipoLABs Healthcare Malaysia.
